Caleb Lee
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 12
- HER2/EGFR in Cancer Research 11
- Cancer-related Molecular Pathways 1
-
- Mosquito-borne diseases and control 11
- Co-authors
- Kenji Tamura (5 shared papers)Toshihiko Doi (3 shared papers)Yoshihiko Fujisaki (2 shared papers)Shanu Modi (5 shared papers)Ian E. Krop (4 shared papers)Rashmi Krishna Murthy (3 shared papers)Hiroji Iwata (6 shared papers)Javad Shahidi (3 shared papers)
- Journals
- The Lancet Oncology (2 papers)New England Journal of Medicine (2 papers)Annals of Oncology (2 papers)Cancer Discovery (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesJapanSingapore
In The Last Decade
Caleb Lee
24 papers receiving 3.4k citations
Caleb Lee's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.7k
- Cancer Research 548
- Pulmonary and Respiratory Medicine 715
- Radiology, Nuclear Medicine and Imaging 504
- Toxicology 53
Countries citing papers authored by Caleb Lee
This map shows the geographic impact of Caleb Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caleb Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caleb Lee more than expected).
Fields of papers citing papers by Caleb Lee
This network shows the impact of papers produced by Caleb Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caleb Lee. The network helps show where Caleb Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Caleb Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer Hit paper breakdown → | 2019 | 1606 |
| 2 | Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study Hit paper breakdown → | 2020 | 633 |
| 3 | 2017 | 431 | |
| 4 | 2019 | 309 | |
| 5 | 2022 | 79 | |
| 6 | 2013 | 60 | |
| 7 | Efficacy of Wolbachia-mediated sterility to reduce the incidence of dengue: a synthetic control study in Singapore Hit paper breakdown → | 2024 | 57 |
| 8 | 2021 | 44 | |
| 9 | 2014 | 33 | |
| 10 | 2020 | 32 | |
| 11 | 2022 | 32 | |
| 12 | 2024 | 32 | |
| 13 | 2005 | 31 | |
| 14 | 2021 | 27 | |
| 15 | 2020 | 24 | |
| 16 | 2022 | 19 | |
| 17 | 2024 | 15 | |
| 18 | 2024 | 15 | |
| 19 | 2024 | 7 | |
| 20 | 2022 | 4 |
About Caleb Lee
Caleb Lee is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Physiology, Pharmacology and Health, Toxicology and Mutagenesis, having authored 26 papers that have together received 3.5k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (11 papers), HER2/EGFR in Cancer Research (11 papers), Clinical Laboratory Practices and Quality Control (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Water Treatment and Disinfection (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Genetic diversity and population structure (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (548 citations), Pulmonary and Respiratory Medicine (715 citations), Radiology, Nuclear Medicine and Imaging (504 citations) and Toxicology (53 citations). Caleb Lee has collaborated with scholars based in United States, Japan and Singapore. Frequent co-authors include Kenji Tamura, Toshihiko Doi, Yoshihiko Fujisaki, Shanu Modi, Ian E. Krop, Rashmi Krishna Murthy, Hiroji Iwata, Javad Shahidi, Shunji Takahashi and Junji Tsurutani. Their work appears in journals such as The Lancet Oncology, New England Journal of Medicine, Annals of Oncology, Cancer Discovery and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.